中华胸心血管外科杂志
中華胸心血管外科雜誌
중화흉심혈관외과잡지
Chinese Journal of Thoracic and Cardiovascular Surgery
2015年
10期
594-599
,共6页
蒙延海%张燕搏%王水云%黄海波%常硕%史晨%刘玲锋
矇延海%張燕搏%王水雲%黃海波%常碩%史晨%劉玲鋒
몽연해%장연박%왕수운%황해파%상석%사신%류령봉
心房颤动%导管消融术%心脏外科手术
心房顫動%導管消融術%心髒外科手術
심방전동%도관소융술%심장외과수술
Atrial fibrillation%Catheter ablation%Cardiac surgical procedures
目的 应用meta分析评价心脏病变合并心房颤动(房颤)患者外科手术同期行射频消融术的临床有效性及安全性.方法 计算机检索PubMed,Embase,Cochrane图书馆,中国学术期刊全文数据库(CNKI)、中国生物医学文献数据光盘数据库(CBM disc)及维普数据库(VIP),比较心脏外科同期行与未行外科消融术的随机对照研究.文献检索时间从建库至2014年11月.风险偏倚表评价纳入文献的质量并提取资料.对符合质量标准的对照研究采用Rev Man 5.2进行异质性检验及meta分析.结果 检出相关文献564篇,根据纳入标准最终入选8篇,入选病例591例.按手术方式分为外科射频消融手术(RFA)组342例,单纯外科(SA)组249例.有效性方面,RFA组术后窦性心律转复率明显高于SA组(OR=10.59;95% CI:3.81~ 29.45),差异有统计学意义(P<0.01);随访6个月、1年及>1年时维持窦性心律患者比例高于SA组(分别P<0.01;P <0.01;P =0.02).安全性方面,两组在术后住院病死率(OR=1.17;95% CI:0.41~ 3.35)、术后随访期病死率(OR=0.77;95% CI:0.35~ 1.69)上差异无统计学意义(分别P=0.76;P=0.52).两组在术后置入起搏器(OR=0.65;95%CI:0.28~ 1.52;P=0.32)、术后血栓事件(OR=1.61;95% CI:0.54~4.84;P =0.40)、因出血再干预(OR=0.45;95% CI:0.12~ 1.70;P=0.24)的发生比例差异均无统计学意义.结论 心外科手术同期行射频消融术可有效维持心脏病变合并房颤患者的窦性心律,有效性和安全性良好.
目的 應用meta分析評價心髒病變閤併心房顫動(房顫)患者外科手術同期行射頻消融術的臨床有效性及安全性.方法 計算機檢索PubMed,Embase,Cochrane圖書館,中國學術期刊全文數據庫(CNKI)、中國生物醫學文獻數據光盤數據庫(CBM disc)及維普數據庫(VIP),比較心髒外科同期行與未行外科消融術的隨機對照研究.文獻檢索時間從建庫至2014年11月.風險偏倚錶評價納入文獻的質量併提取資料.對符閤質量標準的對照研究採用Rev Man 5.2進行異質性檢驗及meta分析.結果 檢齣相關文獻564篇,根據納入標準最終入選8篇,入選病例591例.按手術方式分為外科射頻消融手術(RFA)組342例,單純外科(SA)組249例.有效性方麵,RFA組術後竇性心律轉複率明顯高于SA組(OR=10.59;95% CI:3.81~ 29.45),差異有統計學意義(P<0.01);隨訪6箇月、1年及>1年時維持竇性心律患者比例高于SA組(分彆P<0.01;P <0.01;P =0.02).安全性方麵,兩組在術後住院病死率(OR=1.17;95% CI:0.41~ 3.35)、術後隨訪期病死率(OR=0.77;95% CI:0.35~ 1.69)上差異無統計學意義(分彆P=0.76;P=0.52).兩組在術後置入起搏器(OR=0.65;95%CI:0.28~ 1.52;P=0.32)、術後血栓事件(OR=1.61;95% CI:0.54~4.84;P =0.40)、因齣血再榦預(OR=0.45;95% CI:0.12~ 1.70;P=0.24)的髮生比例差異均無統計學意義.結論 心外科手術同期行射頻消融術可有效維持心髒病變閤併房顫患者的竇性心律,有效性和安全性良好.
목적 응용meta분석평개심장병변합병심방전동(방전)환자외과수술동기행사빈소융술적림상유효성급안전성.방법 계산궤검색PubMed,Embase,Cochrane도서관,중국학술기간전문수거고(CNKI)、중국생물의학문헌수거광반수거고(CBM disc)급유보수거고(VIP),비교심장외과동기행여미행외과소융술적수궤대조연구.문헌검색시간종건고지2014년11월.풍험편의표평개납입문헌적질량병제취자료.대부합질량표준적대조연구채용Rev Man 5.2진행이질성검험급meta분석.결과 검출상관문헌564편,근거납입표준최종입선8편,입선병례591례.안수술방식분위외과사빈소융수술(RFA)조342례,단순외과(SA)조249례.유효성방면,RFA조술후두성심률전복솔명현고우SA조(OR=10.59;95% CI:3.81~ 29.45),차이유통계학의의(P<0.01);수방6개월、1년급>1년시유지두성심률환자비례고우SA조(분별P<0.01;P <0.01;P =0.02).안전성방면,량조재술후주원병사솔(OR=1.17;95% CI:0.41~ 3.35)、술후수방기병사솔(OR=0.77;95% CI:0.35~ 1.69)상차이무통계학의의(분별P=0.76;P=0.52).량조재술후치입기박기(OR=0.65;95%CI:0.28~ 1.52;P=0.32)、술후혈전사건(OR=1.61;95% CI:0.54~4.84;P =0.40)、인출혈재간예(OR=0.45;95% CI:0.12~ 1.70;P=0.24)적발생비례차이균무통계학의의.결론 심외과수술동기행사빈소융술가유효유지심장병변합병방전환자적두성심률,유효성화안전성량호.
Objective The purpose of this sturdy was to conduct a meta-analysis of published randomised controlled trials(RCT) comparing the clinical outcomes of radiofrequency ablation(RFA) versus surgery alone(SA) in all patients with cardiac surgery.Methods PubMed, Embase, the Cochrane Controlled Trials Register databases, CNKI, CBM disc and VIP datebases were searched, and study eligibility and conducted data abstraction were determined independently and in duplicate.Literature searches from database establishment to November 2014.The heterogeneity and data were analyzed by the software of Rev Man 5.2.Results Of 564 studies identified, 8 studies met eligibility criteria, and included a total of 591 patients.In efficacy, The number of patients in sinus rhythm(SR) was signifcantly improved in RFA group compared to SA group at discharge(OR =10.59;95% CI: 3.81-29.45).This effect on SR remained at all follow-up periods until > 1 year.In safety, there was no significant difference in the incidence of hospital mortality(OR =1.17;95% CI: 0.41-3.35) and mortality rate in follow up period(OR =0.77;95% CI: 0.35-1.69) between RFA group and SA group.Similar results were shown in the incidence of permanent pacemaker(OR =0.65;95 % CI: 0.28-1.52;P =0.32) , thromboembolic events (OR =1.61;95 % CI: 0.54-4.84;P =0.40), postoperative re-intervention for bleeding (OR =0.45;95 % CI: 0.12-1.70;P =0.24).Conclusion The results of the current randomized trials demonstrates that concomitant surgical radiofrequency ablation and cardiac surgery is safe and effective at restoring sinus rhythm.